Olivo Sciences has built an AI and data platform to accelerate drug development for brain disorders. It brings together clinical records, brain imaging and molecular data, then applies neurology-trained AI to support drug discovery, improve clinical trial design and identify eligible patients. Its business model combines licensing de-identified neurological datasets with AI applications — turning fragmented healthcare data into tools for developing new therapies.
Olivo’s AI applications help researchers design better trials and find suitable patients. PreciseDesign uses real-world patient data to refine study criteria and predict outcomes, while PreciseEnroll uses AI matching to identify patients who qualify for a trial — addressing key challenges in neurological drug development.
Olivo’s AI applications help researchers design better trials and find suitable patients. PreciseDesign uses real-world patient data to refine study criteria and predict outcomes, while PreciseEnroll uses AI matching to identify patients who qualify for a trial — addressing key challenges in neurological drug development.
Olivo’s AI applications help researchers design better trials and find suitable patients. PreciseDesign uses real-world patient data to refine study criteria and predict outcomes, while PreciseEnroll uses AI matching to identify patients who qualify for a trial — addressing key challenges in neurological drug development.
Register Here to
View Pitch Deck
“If we had worked with Olivo earlier, it would have saved us millions. We definitely want to work with you on our next trial.”
The Team
Azeddine Tebba, MD
Co-Founder & Chief Medical Officer
A physician and AI-driven precision medicine expert with experience leading clinical trial operations and drug development programs in biopharma. His background combines medical expertise with practical experience in therapeutic development.
Kristin Andruska, MD, PhD
Co-Founder & Chief Medical Officer
A neurology and clinical trial expert with experience as a principal investigator and advisor to biopharma companies. Her background also includes leadership roles in several healthcare startups, bringing clinical and entrepreneurial expertise to Olivo.
Amit Masaun
Chief Technology Officer
A technology leader whose background includes serving as a tech lead at Tempus AI and Vice President of Engineering at Deep6 AI. He brings healthcare AI and engineering leadership experience to Olivo’s technical team.
Register Here to
View Pitch Deck
Register Here to
View Pitch Deck
Interested in Investing in Healthcare Innovation?
